Literature DB >> 23400323

A 28-year-old i.v. drug user with bilateral basal ganglia and brainstem lesions.

Tanya P Lin1, Rebecca Thompson, Bruce Coull.   

Abstract

Mesh：

Year:  2013        PMID： 23400323      PMCID： PMC3590060          DOI： 10.1212/WNL.0b013e318281cd02

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  10 in total

1.  Rhizomycosis infection in the basal ganglia.

Authors:  Jeyaraj Durai Pandian; James S McCarthy; Tony Goldschlager; Thomas Robertson; Robert D Henderson
Journal:  Arch Neurol       Date:  2007-01

2.  Encephalitis of the basal ganglia in an injection drug user.

Authors:  Mackenzie Carpenter; Christopher Polk; Rudolph Castellani; Karen Mochoruk; Stephen Sanche; Barney Stern; Michael S Donnenberg
Journal:  Clin Infect Dis       Date:  2007-12-01       Impact factor: 9.079

Review 3.  Epidemiology and clinical manifestations of mucormycosis.

Authors:  George Petrikkos; Anna Skiada; Olivier Lortholary; Emmanuel Roilides; Thomas J Walsh; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2012-02       Impact factor: 9.079

4.  Nonsurgical cure of isolated cerebral mucormycosis in an intravenous drug user.

Authors:  R Blázquez; A Pinedo; J Cosín; P Miralles; C Lacruz; E Bouza
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-07       Impact factor: 3.267

Review 5.  Mucormycosis.

Authors:  A M Sugar
Journal:  Clin Infect Dis       Date:  1992-03       Impact factor: 9.079

Review 6.  Isolated central nervous system mucormycosis.

Authors:  S U Siddiqi; J D Freedman
Journal:  South Med J       Date:  1994-10       Impact factor: 0.954

Review 7.  Isolated cerebral mucormycosis: case report and therapeutic considerations.

Authors:  R Gollard; C Rabb; R Larsen; P Chandrasoma
Journal:  Neurosurgery       Date:  1994-01       Impact factor: 4.654

8.  Successful treatment of a giant isolated cerebral mucormycotic (zygomycotic) abscess using endoscopic debridement: case report and therapeutic considerations.

Authors:  Philippe Metellus; Mehdi Laghmari; Stéphane Fuentes; Alexandre Eusebio; Tarek Adetchessi; Stéphane Ranque; Corinne Bouvier; Henry Dufour; François Grisoli
Journal:  Surg Neurol       Date:  2007-08-17

Review 9.  Cerebral mucormycosis associated with intravenous drug use: three case reports and review.

Authors:  R J Hopkins; M Rothman; A Fiore; S E Goldblum
Journal:  Clin Infect Dis       Date:  1994-12       Impact factor: 9.079

10.  Isolated cerebellar mucormycosis, slowly progressive over 1 year in an immunocompetent patient.

Authors:  Ellen L Air; Achala A Vagal; Ady Kendler; Christopher M McPherson
Journal:  Surg Neurol Int       Date:  2010-12-13
  10 in total
  2 in total

1.  Bilateral Cerebral Mucormycosis in an Immunocompetent Female.

Authors:  Remi T Okwechime; Nicholas Reyes; Darshan Trivedi; Ifeanyi O Iwuchukwu
Journal:  Ochsner J       Date:  2022

2.  Isolated Cerebral Mucormycosis in Immunocompetent Adults who Inject Drugs: Case Reports and Systematic Review of the Literature.

Authors:  Eric A Meyerowitz; Sarimer Sanchez; Michael K Mansour; Virginia A Triant; Marcia B Goldberg
Journal:  Open Forum Infect Dis       Date:  2020-11-13       Impact factor: 3.835
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.